Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Rev Esp Salud Publica ; 74(5-6): 457-74, 2000.
Artigo em Espanhol | MEDLINE | ID: mdl-11217236

RESUMO

A number of recommendations are provided regarding the detection, assessment and management in primary and secondary prevention, approaching hypercholesterolaemia from a multifactorial standpoint based on cardiovascular risk. Cardiovascular diseases are the leading cause of death in Spain. The major risks involved are coronary heart disease and cerebrovascular disease. The demographic, health-related and social impact thereof will be increasing over the coming decades. Controlling hypercholesterolaemia, in conjunction with eradicating the smoking habit and controlling hypertension, diabetes, obesity and physical inactivity comprise one of the main strategies for preventing cardiovascular diseases. Breaking down the risk of individuals based on the major cardiovascular risk factors is essential, given that these factors condition the frequency with which these individuals must be monitored and the type and degree of treatment entailed. Based on this breakdown, the priorities have been set for taking steps to prevent cardiovascular disease. In primary prevention, the therapeutic objective in high-risk persons (20% risk or higher or those persons involving two or more risk factors) has been established as LDL-cholesterol < 130 mg/dl. In secondary prevention, drug treatment is indicated when LDL-cholesterol (130 mg/dl and the therapeutic objective is LDL-cholesterol < 100 mg/dl. Those patients having coronary heart disease must be included in secondary prevention programs that will ensure good, constant clinical and risk factor-related control.


Assuntos
Hipercolesterolemia/prevenção & controle , Doenças Cardiovasculares/etiologia , Doenças Cardiovasculares/prevenção & controle , Protocolos Clínicos , Dieta , Exercício Físico , Seguimentos , Humanos , Hipercolesterolemia/complicações , Hipercolesterolemia/tratamento farmacológico , Desenvolvimento de Programas , Fatores de Risco , Fumar/efeitos adversos , Espanha
2.
Rev Clin Esp ; 184(7): 367-70, 1989 Apr.
Artigo em Espanhol | MEDLINE | ID: mdl-2788902

RESUMO

We report the case history of a female patient suffering of a T lymphoblastic lymphoma with an atypical presentation and evolution, consisting of pleuropericardiac effusion without mediastinic masses that coexists with a plasma cell dyscrasia that fulfils the criteria for stationary multiple myeloma. The possible pathogenic relationship between both processes is discussed, emphasizing the functional evolutive dissociation between the cellular constituents of both neoplasias, immature T lymphoblasts and plasma cells, respectively; this constitutes the first reported case in literature.


Assuntos
Linfoma/patologia , Mieloma Múltiplo/patologia , Neoplasias Primárias Múltiplas/patologia , Idoso , Feminino , Humanos , Linfoma/complicações , Proteínas do Mieloma/análise , Derrame Pericárdico/etiologia , Plasmócitos/patologia , Derrame Pleural/etiologia , Linfócitos T/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA